1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Actelion

Anonymous board for Actelion


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    8
    Views:
    4,933
  2. anonymous
    Replies:
    15
    Views:
    4,701
  3. anonymous
    Replies:
    6
    Views:
    2,575
  4. anonymous
    Replies:
    15
    Views:
    9,516
  5. Anonymous
    Replies:
    64
    Views:
    39,969
  6. anonymous
    Replies:
    2
    Views:
    3,215
  7. anonymous
    Replies:
    27
    Views:
    14,777
  8. anonymous
    Replies:
    6
    Views:
    2,437
  9. anonymous
    Replies:
    1
    Views:
    1,653
  10. anonymous
    Replies:
    2
    Views:
    2,129
  11. anonymous
    Replies:
    2
    Views:
    1,464
  12. anonymous
    Replies:
    7
    Views:
    4,354
  13. anonymous
    Replies:
    1
    Views:
    1,470
  14. anonymous
    Replies:
    5
    Views:
    5,131
  15. Anonymous
    Replies:
    56
    Views:
    22,732
  16. anonymous
    Replies:
    16
    Views:
    7,327
  17. anonymous
    Replies:
    0
    Views:
    2,099
  18. anonymous
    Replies:
    4
    Views:
    2,000
  19. anonymous
    Replies:
    2
    Views:
    1,955
  20. anonymous
    Replies:
    1
    Views:
    2,503

Thread Display Options

Loading...